The Odyssey of Online Grant-Making

Grant proposal writing for the life scientist may get easier in 2002 with the filing of a uniform electronic application for noncompetitive grants, but technical and bureaucratic tie-ups delay attempts to bring science funding into the computer age. The National Science Foundation has made strides in this direction by receiving applications electronically via a system called Fastlane, but the agency prints and circulates paper rather than electronic copies once the applications arrive. At the Na

Written byLiane Reif-lehrer
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Electronic NIH grant application submissions are at least another year away, says Pamela Webb, director of research and sponsored programs at the Chicago Campus of Northwestern University. Webb is one of 16 members of an NIH advisory committee that is assisting in a $33 million, one-year NIH electronic grants administration initiative. But the project is turning out to be more complex than the agency predicted. Not only does the agency have to work out a seamless electronic filing process, but it must also create online systems for the multiple reviews, awards, and reports required in grant making. "Once you start looking under the hood, it's an incredibly complex process," explains Webb. "It's much more complex than it appears to be on the surface. There are so many pieces of data in the life cycle of a process."

NIH expects to bring a pilot electronic streamlined non-competing application process (ESNAP) online ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies